(CL) Colgate-Palmolive - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1941621039
CL: Toothpaste, Soap, Shampoo, Detergent, Cleaners, Petfood
Colgate-Palmolive Company (NYSE:CL) is a storied consumer goods giant with a footprint that spans over two centuries. Founded in 1806 and headquartered in New York, the company operates in two primary segments: Oral, Personal, and Home Care, and Pet Nutrition. The first segment is a powerhouse, offering a wide array of everyday essentials like toothpaste, toothbrushes, mouthwash, and hand soaps under iconic brands such as Colgate, Palmolive, and Irish Spring. It also extends into premium skincare with brands like Filorga and PCA SKIN, catering to evolving consumer demands for higher-end personal care products. This segments reach is extensive, with distribution across traditional retail, wholesale, and a growing presence in eCommerce.
The Pet Nutrition segment is another critical pillar, dominated by the Hills Science Diet and Hills Prescription Diet brands. These products are tailored to meet the nutritional needs of pets, ranging from everyday nutrition to specialized, veterinarian-recommended diets. The segments distribution channels include pet supply retailers, veterinarians, and online platforms, ensuring accessibility for pet owners globally. This vertical has significant growth potential, given the rising trend of pet humanization and increased spending on pet health.
From a financial perspective, Colgate-Palmolives market cap stands at approximately $70 billion, reflecting its scale and stability. The companys P/E ratio of 24.70 indicates a premium valuation, likely due to its consistent cash flows and market leadership. The forward P/E of 22.94 suggests expectations of continued earnings growth. While the P/B ratio of 334.36 appears high, it underscores the markets confidence in the companys intangible assets, particularly its strong brand portfolio. The P/S ratio of 3.49 highlights reasonable revenue multiples for a consumer staples giant with a proven track record.
For investors and fund managers, Colgate-Palmolive represents a classic defensive play in the consumer staples sector. Its diversified portfolio of brands, steady cash flows, and global distribution network provide resilience against economic downturns. Additionally, the companys commitment to innovation and sustainability initiatives aligns with evolving consumer preferences, positioning it well for long-term growth. The stocks stability and dividend history make it a favored choice for income-seeking investors looking to balance their portfolios.
Additional Sources for CL Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CL Stock Overview
Market Cap in USD | 72,608m |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
GiC Sub-Industry | Household Products |
IPO / Inception | 1977-01-03 |
CL Stock Ratings
Growth 5y | 39.8% |
Fundamental | 66.6% |
Dividend | 58.6% |
Rel. Strength Industry | -5.74 |
Analysts | 3.74/5 |
Fair Price Momentum | 83.82 USD |
Fair Price DCF | 100.97 USD |
CL Dividends
Dividend Yield 12m | 2.19% |
Yield on Cost 5y | 3.02% |
Annual Growth 5y | 2.50% |
Payout Consistency | 99.6% |
CL Growth Ratios
Growth Correlation 3m | -85.9% |
Growth Correlation 12m | 20% |
Growth Correlation 5y | 67.5% |
CAGR 5y | 6.20% |
CAGR/Max DD 5y | 0.30 |
Sharpe Ratio 12m | 0.19 |
Alpha | 0.64 |
Beta | 0.09 |
Volatility | 20.00% |
Current Volume | 4747.3k |
Average Volume 20d | 4690.5k |
As of February 22, 2025, the stock is trading at USD 89.47 with a total of 4,747,346 shares traded.
Over the past week, the price has changed by +3.99%, over one month by +1.41%, over three months by -4.53% and over the past year by +7.16%.
Yes, based on ValueRay Fundamental Analyses, Colgate-Palmolive (NYSE:CL) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.55 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CL as of February 2025 is 83.82. This means that CL is currently overvalued and has a potential downside of -6.31%.
Colgate-Palmolive has received a consensus analysts rating of 3.74. Therefor, it is recommend to hold CL.
- Strong Buy: 7
- Buy: 6
- Hold: 8
- Sell: 1
- Strong Sell: 1
According to ValueRays Forecast Model, CL Colgate-Palmolive will be worth about 90.8 in February 2026. The stock is currently trading at 89.47. This means that the stock has a potential upside of +1.5%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 97.3 | 8.7% |
Analysts Target Price | 103.1 | 15.2% |
ValueRay Target Price | 90.8 | 1.5% |